{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:50:36Z","timestamp":1764791436406,"version":"3.46.0"},"reference-count":37,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Endosalpingiosis is a benign M\u00fcllerian inclusion that can mimic metastatic low-grade mammary carcinoma, particularly when encountered in axillary lymph nodes excised for breast cancer staging. Immunohistochemistry can be useful in histologically ambiguous cases, and a targeted immunopanel should include a marker of gynecologic tract origin and a marker of mammary origin. GATA3 is a sensitive immunomarker for breast carcinoma, but the immunoreactivity of GATA3 in endosalpingiosis has not been systematically evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To evaluate whether GATA3 immunohistochemistry could be used to differentiate endosalpingiosis from metastatic mammary carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Whole slide sections of 15 cases of endosalpingiosis involving nonneoplastic tissues were subjected to GATA3 immunohistochemistry. Nuclear GATA3 labeling was scored as percentage and intensity labeling, with any labeling considered positive; GATA3 labeling was recorded in all cells present in the sections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Half (47%, n = 7 of 15) of the endosalpingiosis cases involved lymph nodes (2 axillary, 5 pelvic) and half (53%, n = 8 of 15) involved pelvic organs or soft tissue (3 myometrial, 2 paratubal, 2 periadnexal soft tissue, and 1 pelvic sidewall). GATA3 immunohistochemistry was negative in all cases of endosalpingiosis, with intact, positive control labeling in lymphocytes. The benign fallopian tube epithelium present on the sections of paratubal endosalpingiosis displayed focal (&amp;lt;5%), weak labeling for GATA3, specifically within the ciliated and secretory cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>These findings support the diagnostic utility of GATA3 immunohistochemistry and its use in a targeted immunopanel to resolve the differential diagnosis of metastatic low-grade mammary carcinoma (GATA3+) and nodal endosalpingiosis (GATA3\u2212).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2020-0359-oa","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T14:09:50Z","timestamp":1613052590000},"page":"1448-1452","source":"Crossref","is-referenced-by-count":3,"title":["Endosalpingiosis Is Negative for GATA3"],"prefix":"10.5858","volume":"145","author":[{"given":"Marissa J.","family":"White","sequence":"first","affiliation":[{"name":"From the Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Argani","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Cimino-Mathews","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, the Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"2021102118015363900_i1543-2165-145-11-1448-b01","doi-asserted-by":"crossref","unstructured":"Miettinen\n              M,\n            \n            \n              McCue\n              PA,\n            \n            \n              Sarlomo-Rikala\n              M,\n            \n            et al.\n          \n          GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t38(1):\n\t\t\t\t\t13\u2013\n\t\t\t\t\t22.","DOI":"10.1097\/PAS.0b013e3182a0218f"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b02","doi-asserted-by":"crossref","unstructured":"Asch-Kendrick\n              R,\n            \n            \n              Cimino-Mathews\n              A.\n            \n          \n          The role of GATA3 in breast carcinomas: a review.\n\t\t\t\t\tHum Pathol.\n\t\t\t\t\t2016;\n\t\t\t\t\t48:\n\t\t\t\t\t37\u2013\n\t\t\t\t\t47.","DOI":"10.1016\/j.humpath.2015.09.035"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b03","doi-asserted-by":"crossref","unstructured":"Liu\n              H,\n            \n            \n              Shi\n              J,\n            \n            \n              Wilkerson\n              ML,\n            \n            \n              Lin\n              F.\n            \n          \n          Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.\n\t\t\t\t\tAm J Clin Pathol.\n\t\t\t\t\t2012;\n\t\t\t\t\t138(1):\n\t\t\t\t\t57\u2013\n\t\t\t\t\t64.","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b04","doi-asserted-by":"crossref","unstructured":"Voduc\n              D,\n            \n            \n              Cheang\n              M,\n            \n            \n              Nielsen\n              T.\n            \n          \n          GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.\n\t\t\t\t\tCancer Epidemiol Biomarkers Prev.\n\t\t\t\t\t2008;\n\t\t\t\t\t17(2):\n\t\t\t\t\t365\u2013\n\t\t\t\t\t373.","DOI":"10.1158\/1055-9965.EPI-06-1090"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b05","doi-asserted-by":"crossref","unstructured":"Cimino-Mathews\n              A,\n            \n            \n              Subhawong\n              AP,\n            \n            \n              Illei\n              PB,\n            \n            et al.\n          \n          GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.\n\t\t\t\t\tHum Pathol.\n\t\t\t\t\t2013;\n\t\t\t\t\t44(7):\n\t\t\t\t\t1341\u2013\n\t\t\t\t\t1349.","DOI":"10.1016\/j.humpath.2012.11.003"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b06","doi-asserted-by":"crossref","unstructured":"Clark\n              BZ,\n            \n            \n              Beriwal\n              S,\n            \n            \n              Dabbs\n              DJ,\n            \n            \n              Bhargava\n              R.\n            \n          \n          Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.\n\t\t\t\t\tAm J Clin Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t142(1):\n\t\t\t\t\t64\u2013\n\t\t\t\t\t71.","DOI":"10.1309\/AJCP8H2VBDSCIOBF"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b07","doi-asserted-by":"crossref","unstructured":"Braxton\n              DR,\n            \n            \n              Cohen\n              C,\n            \n            \n              Siddiqui\n              MT.\n            \n          \n          Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.\n\t\t\t\t\tDiagn Cytopathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t43(4):\n\t\t\t\t\t271\u2013\n\t\t\t\t\t277.","DOI":"10.1002\/dc.23206"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b08","doi-asserted-by":"crossref","unstructured":"Sangoi\n              AR,\n            \n            \n              Shrestha\n              B,\n            \n            \n              Yang\n              G,\n            \n            \n              Mego\n              O,\n            \n            \n              Beck\n              AH.\n            \n          \n          The novel marker GATA3 is significantly more sensitive than traditional markers mammaglobin and GCDFP15 for identifying breast cancer in surgical and cytology specimens of metastatic and matched primary tumors.\n\t\t\t\t\tAppl Immunohistochem Mol Morphol.\n\t\t\t\t\t2016;\n\t\t\t\t\t24(4):\n\t\t\t\t\t229\u2013\n\t\t\t\t\t237.","DOI":"10.1097\/PAI.0000000000000186"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b09","doi-asserted-by":"crossref","unstructured":"Wendroth\n              SM,\n            \n            \n              Mentrikoski\n              MJ,\n            \n            \n              Wick\n              MR.\n            \n          \n          GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.\n\t\t\t\t\tAnn Diagn Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t19(1):\n\t\t\t\t\t6\u2013\n\t\t\t\t\t9.","DOI":"10.1016\/j.anndiagpath.2014.12.001"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b10","doi-asserted-by":"crossref","unstructured":"Gown\n              AM,\n            \n            \n              Fulton\n              RS,\n            \n            \n              Kandalaft\n              PL.\n            \n          \n          Markers of metastatic carcinoma of breast origin.\n\t\t\t\t\tHistopathology.\n\t\t\t\t\t2016;\n\t\t\t\t\t68(1):\n\t\t\t\t\t86\u2013\n\t\t\t\t\t95.","DOI":"10.1111\/his.12877"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b11","doi-asserted-by":"crossref","unstructured":"Carney\n              E,\n            \n            \n              Cimino-Mathews\n              A,\n            \n            \n              Argani\n              C,\n            \n            \n              Kronz\n              J,\n            \n            \n              Vang\n              R,\n            \n            \n              Argani\n              P.\n            \n          \n          A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t38(12):\n\t\t\t\t\t1612\u2013\n\t\t\t\t\t1617.","DOI":"10.1097\/PAS.0000000000000261"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b12","doi-asserted-by":"crossref","unstructured":"Ozcan\n              A,\n            \n            \n              Liles\n              N,\n            \n            \n              Coffey\n              D,\n            \n            \n              Shen\n              SS,\n            \n            \n              Truong\n              LD.\n            \n          \n          PAX2 and PAX8 expression in primary and metastatic m\u00fcllerian epithelial tumors: a comprehensive comparison.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2011;\n\t\t\t\t\t35(12):\n\t\t\t\t\t1837\u2013\n\t\t\t\t\t1847.","DOI":"10.1097\/PAS.0b013e31822d787c"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b13","doi-asserted-by":"crossref","unstructured":"Laury\n              AR,\n            \n            \n              Perets\n              R,\n            \n            \n              Piao\n              H,\n            \n            et al.\n          \n          A comprehensive analysis of PAX8 expression in human epithelial tumors.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2011;\n\t\t\t\t\t35(6):\n\t\t\t\t\t816\u2013\n\t\t\t\t\t826.","DOI":"10.1097\/PAS.0b013e318216c112"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b14","doi-asserted-by":"crossref","unstructured":"Tacha\n              D,\n            \n            \n              Zhou\n              D,\n            \n            \n              Cheng\n              L.\n            \n          \n          Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.\n\t\t\t\t\tAppl Immunohistochem Mol Morphol.\n\t\t\t\t\t2011;\n\t\t\t\t\t19(4):\n\t\t\t\t\t293\u2013\n\t\t\t\t\t299.","DOI":"10.1097\/PAI.0b013e3182025f66"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b15","doi-asserted-by":"crossref","unstructured":"Shimizu\n              M,\n            \n            \n              Toki\n              T,\n            \n            \n              Takagi\n              Y,\n            \n            \n              Konishi\n              I,\n            \n            \n              Fujii\n              S.\n            \n          \n          Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors.\n\t\t\t\t\tInt J Gynecol Pathol.\n\t\t\t\t\t2000;\n\t\t\t\t\t19(2):\n\t\t\t\t\t158\u2013\n\t\t\t\t\t163.","DOI":"10.1097\/00004347-200004000-00010"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b16","doi-asserted-by":"crossref","unstructured":"Scharnhorst\n              V,\n            \n            \n              van der Eb\n              AJ,\n            \n            \n              Jochemsen\n              AG.\n            \n          \n          WT1 proteins: functions in growth and differentiation.\n\t\t\t\t\tGene.\n\t\t\t\t\t2001;\n\t\t\t\t\t273(2):\n\t\t\t\t\t141\u2013\n\t\t\t\t\t161.","DOI":"10.1016\/S0378-1119(01)00593-5"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b17","doi-asserted-by":"crossref","unstructured":"Siegel\n              RL,\n            \n            \n              Miller\n              KD,\n            \n            \n              Jemal\n              A.\n            \n          \n          Cancer statistics, 2020.\n\t\t\t\t\tCA Cancer J Clin.\n\t\t\t\t\t2020;\n\t\t\t\t\t70(1):\n\t\t\t\t\t7\u2013\n\t\t\t\t\t30.","DOI":"10.3322\/caac.21590"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b18","doi-asserted-by":"crossref","unstructured":"Whelan\n              TJ,\n            \n            \n              Olivotto\n              IA,\n            \n            \n              Parulekar\n              WR,\n            \n            et al.\n          \n          Regional nodal irradiation in early-stage breast cancer.\n\t\t\t\t\tN Engl J Med.\n\t\t\t\t\t2015;\n\t\t\t\t\t373(4):\n\t\t\t\t\t307\u2013\n\t\t\t\t\t316.","DOI":"10.1056\/NEJMoa1415340"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b19","doi-asserted-by":"crossref","unstructured":"S\u00e1volt\n              \u00c1,\n            \n            \n              P\u00e9ley\n              G,\n            \n            \n              Polg\u00e1r\n              C,\n            \n            et al.\n          \n          Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial.\n\t\t\t\t\tEur J Surg Oncol.\n\t\t\t\t\t2017;\n\t\t\t\t\t43(4):\n\t\t\t\t\t672\u2013\n\t\t\t\t\t679.","DOI":"10.1093\/annonc\/mdx362.016"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b20","doi-asserted-by":"crossref","unstructured":"Bleiweiss\n              IJ,\n            \n            \n              Nagi\n              CS,\n            \n            \n              Jaffer\n              S.\n            \n          \n          Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma.\n\t\t\t\t\tJ Clin Oncol.\n\t\t\t\t\t2006;\n\t\t\t\t\t24(13):\n\t\t\t\t\t2013\u2013\n\t\t\t\t\t2018.","DOI":"10.1200\/JCO.2005.04.7076"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b21","doi-asserted-by":"crossref","unstructured":"Poling\n              JS,\n            \n            \n              Tsangaris\n              TN,\n            \n            \n              Argani\n              P,\n            \n            \n              Cimino-Mathews\n              A.\n            \n          \n          Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases.\n\t\t\t\t\tBreast Cancer Res Treat.\n\t\t\t\t\t2014;\n\t\t\t\t\t148(2):\n\t\t\t\t\t355\u2013\n\t\t\t\t\t361.","DOI":"10.1007\/s10549-014-3161-x"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b22","doi-asserted-by":"crossref","unstructured":"Brogi\n              E,\n            \n            \n              Torres-Matundan\n              E,\n            \n            \n              Tan\n              LK,\n            \n            \n              Cody\n              HS\n              III.\n            \n          \n          The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients.\n\t\t\t\t\tAnn Surg Oncol.\n\t\t\t\t\t2005;\n\t\t\t\t\t12(2):\n\t\t\t\t\t173\u2013\n\t\t\t\t\t180.","DOI":"10.1245\/ASO.2005.03.067"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b23","doi-asserted-by":"crossref","unstructured":"Akay\n              CL,\n            \n            \n              Albarracin\n              C,\n            \n            \n              Torstenson\n              T,\n            \n            et al.\n          \n          Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.\n\t\t\t\t\tBreast J.\n\t\t\t\t\t2018;\n\t\t\t\t\t24(1):\n\t\t\t\t\t28\u2013\n\t\t\t\t\t34.","DOI":"10.1111\/tbj.12829"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b24","doi-asserted-by":"crossref","unstructured":"Lombardi\n              A,\n            \n            \n              Nigri\n              G,\n            \n            \n              Maggi\n              S,\n            \n            et al.\n          \n          Role of frozen section in sentinel lymph node biopsy for breast cancer in the era of the ACOSOG Z0011 and IBCSG 23-10 trials.\n\t\t\t\t\tSurgeon.\n\t\t\t\t\t2018;\n\t\t\t\t\t16(4):\n\t\t\t\t\t232\u2013\n\t\t\t\t\t236.","DOI":"10.1016\/j.surge.2017.11.003"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b25","doi-asserted-by":"crossref","unstructured":"Norton\n              LE,\n            \n            \n              Komenaka\n              IK,\n            \n            \n              Emerson\n              RE,\n            \n            \n              Murphy\n              C,\n            \n            \n              Badve\n              S.\n            \n          \n          Benign glandular inclusions a rare cause of a false positive sentinel node.\n\t\t\t\t\tJ Surg Oncol.\n\t\t\t\t\t2007;\n\t\t\t\t\t95(7):\n\t\t\t\t\t593\u2013\n\t\t\t\t\t596.","DOI":"10.1002\/jso.20749"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b26","doi-asserted-by":"crossref","unstructured":"Chao\n              C,\n            \n            \n              Wong\n              SL,\n            \n            \n              Ackermann\n              D,\n            \n            et al.\n          \n          Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer.\n\t\t\t\t\tAm J Surg.\n\t\t\t\t\t2001;\n\t\t\t\t\t182(6):\n\t\t\t\t\t609\u2013\n\t\t\t\t\t615.","DOI":"10.1016\/S0002-9610(01)00794-2"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b27","doi-asserted-by":"crossref","unstructured":"Cimino-Mathews\n              A.\n            \n          \n          Axillary lymph node inclusions.\n\t\t\t\t\tSurg Pathol Clin.\n\t\t\t\t\t2018;\n\t\t\t\t\t11(1):\n\t\t\t\t\t43\u2013\n\t\t\t\t\t59.","DOI":"10.1016\/j.path.2017.09.004"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b28","doi-asserted-by":"crossref","unstructured":"Corben\n              AD,\n            \n            \n              Nehhozina\n              T,\n            \n            \n              Garg\n              K,\n            \n            \n              Vallejo\n              CE,\n            \n            \n              Brogi\n              E.\n            \n          \n          Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2010;\n\t\t\t\t\t34(8):\n\t\t\t\t\t1211\u2013\n\t\t\t\t\t1216.","DOI":"10.1097\/PAS.0b013e3181e5e03e"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b29","doi-asserted-by":"crossref","unstructured":"Mukonoweshuro\n              P,\n            \n            \n              McCluggage\n              WG.\n            \n          \n          Endocervicosis involving axillary lymph nodes: first case report.\n\t\t\t\t\tInt J Gynecol Pathol.\n\t\t\t\t\t2014;\n\t\t\t\t\t33(6):\n\t\t\t\t\t620\u2013\n\t\t\t\t\t623.","DOI":"10.1097\/PGP.0000000000000089"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b30","doi-asserted-by":"crossref","unstructured":"Stolnicu\n              S,\n            \n            \n              Preda\n              O,\n            \n            \n              Kinga\n              S,\n            \n            et al.\n          \n          Florid, papillary endosalpingiosis of the axillary lymph nodes.\n\t\t\t\t\tBreast J.\n\t\t\t\t\t2011;\n\t\t\t\t\t17(3):\n\t\t\t\t\t268\u2013\n\t\t\t\t\t272.","DOI":"10.1111\/j.1524-4741.2011.01081.x"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b31","doi-asserted-by":"crossref","unstructured":"Nadji\n              M,\n            \n            \n              Gomez-Fernandez\n              C,\n            \n            \n              Ganjei-Azar\n              P,\n            \n            \n              Morales\n              AR.\n            \n          \n          Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.\n\t\t\t\t\tAm J Clin Pathol.\n\t\t\t\t\t2005;\n\t\t\t\t\t123(1):\n\t\t\t\t\t21\u2013\n\t\t\t\t\t27.","DOI":"10.1309\/4WV79N2GHJ3X1841"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b32","doi-asserted-by":"crossref","unstructured":"Domfeh\n              AB,\n            \n            \n              Carley\n              AL,\n            \n            \n              Striebel\n              JM,\n            \n            et al.\n          \n          WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes.\n\t\t\t\t\tMod Pathol.\n\t\t\t\t\t2008;\n\t\t\t\t\t21(10):\n\t\t\t\t\t1217\u2013\n\t\t\t\t\t1223.","DOI":"10.1038\/modpathol.2008.69"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b33","doi-asserted-by":"crossref","unstructured":"Waldstr\u00f8m\n              M,\n            \n            \n              Grove\n              A.\n            \n          \n          Immunohistochemical expression of Wilms tumor gene protein in different histologic subtypes of ovarian carcinomas.\n\t\t\t\t\tArch Pathol Lab Med.\n\t\t\t\t\t2005;\n\t\t\t\t\t129(1):\n\t\t\t\t\t85\u2013\n\t\t\t\t\t88.","DOI":"10.5858\/2005-129-85-IEOWTG"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b34","doi-asserted-by":"crossref","unstructured":"Shiino\n              S,\n            \n            \n              Yoshida\n              M,\n            \n            \n              Jimbo\n              K,\n            \n            et al.\n          \n          Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer.\n\t\t\t\t\tVirchows Arch.\n\t\t\t\t\t2019;\n\t\t\t\t\t474(5):\n\t\t\t\t\t633\u2013\n\t\t\t\t\t638.","DOI":"10.1007\/s00428-019-02521-z"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b35","doi-asserted-by":"crossref","unstructured":"Roma\n              AA,\n            \n            \n              Goyal\n              A,\n            \n            \n              Yang\n              B.\n            \n          \n          Differential expression patterns of GATA3 in uterine mesonephric and nonmesonephric lesions.\n\t\t\t\t\tInt J Gynecol Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t34(5):\n\t\t\t\t\t480\u2013\n\t\t\t\t\t486.","DOI":"10.1097\/PGP.0000000000000167"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b36","doi-asserted-by":"crossref","unstructured":"Ronaghy\n              A,\n            \n            \n              Xiao\n              GQ,\n            \n            \n              Santagada\n              E,\n            \n            \n              Hasanovic\n              A,\n            \n            \n              Unger\n              P.\n            \n          \n          Expression of GATA-3 in testicular and gynecologic mesothelial neoplastic and non-neoplastic tissues.\n\t\t\t\t\tInt J Gynecol Pathol.\n\t\t\t\t\t2018;\n\t\t\t\t\t37(3):\n\t\t\t\t\t284\u2013\n\t\t\t\t\t289.","DOI":"10.1097\/PGP.0000000000000403"},{"key":"2021102118015363900_i1543-2165-145-11-1448-b37","doi-asserted-by":"crossref","unstructured":"Banet\n              N,\n            \n            \n              Gown\n              AM,\n            \n            \n              Shih\n              IeM,\n            \n            et al.\n          \n          GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.\n\t\t\t\t\tAm J Surg Pathol.\n\t\t\t\t\t2015;\n\t\t\t\t\t39(1):\n\t\t\t\t\t101\u2013\n\t\t\t\t\t108.","DOI":"10.1097\/PAS.0000000000000315"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/11\/1448\/2937935\/i1543-2165-145-11-1448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/145\/11\/1448\/2937935\/i1543-2165-145-11-1448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:55Z","timestamp":1764790735000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/145\/11\/article-p1448.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,2,11]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2020-0359-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2021,2,11]]}}}